Denali Therapeutics
NASDAQ: DNLI
Developing therapies for neurodegenerative diseases through rigorous research.
Developing therapies for neurodegenerative diseases through rigorous research.
Sector
Life SciencesCategory
TherapeuticsLocation
San Francisco, CAInitial Investment
Created 2015Denali Therapeutics (NASDAQ:DNLI) is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
“The team at F-Prime led the funding of Denali and helped create a company focused on solving big medical problems. They brought the scientific and business firepower to rapidly found and grow Denali.”
Ryan Watts, CEO
